CNS
Overvalued by 49.5% based on the discounted cash flow analysis.
Market cap | $3.46 Billion |
---|---|
Enterprise Value | $3.27 Billion |
Dividend Yield | $2.2693 (3.25%) |
Earnings per Share | $2.6 |
Beta | 0.0 |
Outstanding Shares | 49,525,092 |
Avg 30 Day Volume | 560,406 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 26.81 |
---|---|
PEG | -324.98 |
Price to Sales | 7.74 |
Price to Book Ratio | 9.95 |
Enterprise Value to Revenue | 6.68 |
Enterprise Value to EBIT | 19.39 |
Enterprise Value to Net Income | 25 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data